Abiomed, inc. (ABMD)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10
Operating activities:
Net income

203,009

245,171

220,817

257,873

259,016

221,903

190,486

164,862

112,170

90,222

92,208

76,580

52,116

48,215

43,338

42,198

38,147

126,023

128,152

124,256

113,688

18,436

10,145

7,365

7,351

7,471

5,762

10,172

15,014

13,839

14,076

9,208

1,495

-2,844

-6,567

-10,369

-11,755

0

0

0

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation expense

20,430

18,612

16,826

15,527

14,121

12,841

12,032

11,501

11,005

9,814

8,564

7,259

6,202

5,551

4,883

4,020

3,277

3,188

2,926

2,812

2,770

2,441

2,382

2,477

2,508

2,500

2,596

2,533

2,723

3,339

3,660

4,132

4,336

4,023

3,969

4,035

3,948

0

0

0

Bad debt expense (recovery)

487

383

405

511

720

624

559

268

38

163

118

148

159

-48

47

48

42

30

-50

-73

-5

79

59

63

47

2

42

40

33

87

58

110

117

79

77

101

139

0

0

0

Stock-based compensation

39,781

47,756

52,760

55,370

54,494

54,940

50,594

43,942

40,353

37,515

32,757

33,125

32,866

31,843

31,508

32,651

29,053

25,555

23,798

17,029

16,520

15,547

12,813

11,587

11,218

10,969

11,257

10,743

9,501

8,768

8,605

8,120

7,773

7,307

6,806

6,382

5,421

0

0

0

Write-down of inventory and other

4,249

5,084

4,676

4,614

4,252

3,886

3,151

4,333

3,946

4,238

4,259

2,887

3,085

2,797

2,496

2,503

2,094

2,452

2,624

2,324

2,231

2,506

2,034

2,011

2,012

922

1,111

1,127

1,172

1,632

2,055

1,929

1,833

1,493

1,793

2,314

2,781

0

0

0

Accretion on marketable securities

2,731

3,778

4,172

3,687

2,744

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of other investments

-5,184

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Excess tax benefit from stock-based awards

-

-

-

-

-

-

-

-

-

-

-

-

12,038

7,674

6,815

4,527

3,567

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-29

0

0

0

Deferred tax provision

32,953

48,798

48,126

47,494

-7,745

-18,108

-6,125

1,991

42,624

41,726

19,099

14,973

25,803

23,731

21,270

23,491

22,296

-70,387

-76,741

-81,514

-87,094

856

857

859

860

889

891

891

755

779

785

783

789

797

806

823

970

0

0

0

Change in fair value of contingent consideration

-575

-143

-257

-400

-915

160

658

913

1,337

2,248

2,086

1,679

1,590

783

932

1,078

1,053

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-cash operating activities

4,108

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of WorldHeart common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

456

0

0

0

Changes in assets and liabilities:
Accounts receivable

-5,551

13,088

20,720

19,152

22,023

24,215

17,596

14,154

15,289

14,337

10,567

12,272

11,550

13,401

9,523

6,957

10,930

8,734

14,292

11,974

7,970

5,755

2,116

1,735

1,312

2,952

2,280

2,647

2,586

2,671

3,443

4,099

5,284

4,540

576

1,843

1,923

0

0

0

Inventories

13,237

23,920

32,635

36,626

37,181

30,234

27,073

22,178

15,686

15,643

11,363

10,193

12,284

9,996

10,902

10,317

11,473

13,477

13,169

11,282

6,967

4,135

399

-833

622

486

1,983

5,022

5,315

7,090

7,875

6,610

6,229

4,881

4,521

3,754

1,508

0

0

0

Prepaid expenses and other assets

5,333

7,455

4,617

3,813

2,527

2,755

5,584

5,682

4,466

-524

1,206

3,288

2,366

6,556

4,775

2,746

2,290

956

884

761

1,479

874

416

1,586

1,039

1,030

995

-31

326

-49

446

524

239

556

192

-89

-161

0

0

0

Accounts payable

2,581

3,908

7,996

3,829

7,976

6,726

4,874

11,487

4,412

6,618

5,958

3,319

7,565

2,637

1,078

-1,023

-2,645

1,264

2,136

2,654

3,372

1,993

859

199

-54

-210

844

181

1,183

909

986

1,347

287

1,682

618

415

2,480

0

0

0

Accrued expenses and other liabilities

15,676

17,690

11,312

13,339

13,406

10,757

11,722

3,582

7,722

15,057

15,892

20,739

22,223

20,428

15,851

11,131

10,020

7,282

7,069

4,867

6,011

1,195

184

3,416

1,938

1,795

1,892

2,684

3,057

2,959

2,506

2,089

-1,330

-2,698

-2,833

-2,669

605

0

0

0

Deferred revenue

2,787

4,101

5,417

4,127

1,508

3,324

3,436

2,381

4,380

2,700

1,433

1,071

1,745

2,108

2,287

711

1,718

328

1,066

2,702

2,309

2,268

1,625

1,200

559

1,249

1,242

1,305

1,178

1,210

1,082

987

1,050

-111

286

334

682

0

0

0

Net cash provided by operating activities

314,920

298,718

283,893

270,194

252,197

238,205

220,286

202,883

192,546

173,402

150,831

125,030

115,116

100,418

91,675

92,261

76,795

72,501

62,244

51,014

43,290

34,922

28,246

26,689

23,466

21,129

20,389

22,048

26,399

23,834

21,056

16,508

3,634

-1,213

-281

-4,335

1,574

0

0

0

Investing activities:
Purchases of marketable securities

611,280

611,370

517,131

460,967

361,602

357,319

306,430

276,484

325,408

310,744

276,200

284,809

278,501

248,971

296,208

285,632

260,975

214,842

151,740

115,795

97,658

101,107

98,097

96,149

87,026

83,507

64,528

53,330

49,429

31,752

35,251

31,001

24,502

18,503

14,503

11,504

8,004

0

0

0

Proceeds from the sale and maturity of marketable securities and other

550,788

515,393

457,923

349,284

331,886

285,763

248,337

216,069

206,909

208,907

184,213

225,014

205,482

194,114

234,871

216,466

219,639

183,835

125,093

86,063

71,530

73,891

90,405

86,245

68,265

73,764

62,250

54,250

42,000

21,250

6,250

8,750

7,750

9,000

9,000

7,500

7,000

0

0

0

Purchases of other investments and intangible assets

20,957

33,198

39,109

44,369

42,735

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

750

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the sale of WorldHeart common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

456

0

0

0

Purchases of property and equipment

44,006

41,995

41,266

41,107

44,004

47,164

65,533

61,206

55,863

70,544

57,637

55,120

50,415

31,730

22,658

18,860

15,624

10,889

7,111

6,671

5,188

2,692

3,021

2,430

2,761

3,065

2,449

3,077

2,836

1,880

2,231

1,743

1,745

2,687

2,350

1,987

1,804

0

0

0

Net cash used for investing activities

-125,455

-171,170

-139,583

-197,159

-116,455

-149,156

-135,052

-128,787

-180,762

-181,531

-158,923

-118,214

-126,333

-86,736

-83,995

-88,776

-57,710

-44,246

-36,608

-54,950

-49,863

-46,855

-27,160

-12,334

-22,272

-13,558

-5,477

-2,907

-10,265

-12,382

-30,215

-22,977

-17,480

-11,173

-7,853

-5,774

-2,352

0

0

0

Financing activities:
Proceeds from the exercise of stock options

3,700

5,057

4,987

8,402

12,900

12,717

14,656

11,543

9,300

10,021

10,153

11,445

10,660

9,799

7,564

7,952

9,771

10,540

16,338

14,696

10,927

9,757

6,602

8,249

9,360

8,424

5,761

3,639

2,936

5,313

8,950

7,856

14,257

12,328

8,518

8,596

1,061

0

0

0

Taxes paid related to net share settlement upon vesting of stock awards

41,687

42,170

43,316

44,714

71,776

71,670

70,746

70,110

20,317

20,067

19,734

22,877

20,105

23,303

23,111

18,881

7,313

5,700

5,602

5,257

2,805

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Excess tax benefit from stock-based awards

-

-

-

-

-

-

-

-

-

-

-

-

12,038

7,674

6,815

4,527

3,567

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the issuance of stock under employee stock purchase plan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,135

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Principal payments on capital lease obligation

-

-

-

-

-

-

-

-

517

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments in lieu of issuance of common stock for minimum payroll taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

-

-

-

-

-

-

-

-

Net cash used for financing activities

-117,715

-92,931

-69,102

-33,251

-55,775

-56,243

-53,521

-56,503

-9,137

-1,288

100

655

3,867

-4,641

-7,362

-5,272

7,160

6,783

12,574

10,926

9,523

9,527

6,372

7,934

9,632

4,185

-9,132

-11,296

-11,811

-5,186

9,208

8,041

14,680

12,788

8,875

8,909

1,374

0

0

0

Effect of exchange rate changes on cash

-430

-828

-1,311

-24

-1,921

873

133

-275

1,288

-1,150

-2,181

-1,775

-1,841

-1,198

-30

-370

-415

-1,290

-1,272

-1,299

-1,465

-748

-95

724

639

119

-157

-107

-862

-601

-890

-1,734

-675

497

446

1,410

447

0

0

0

Net increase in cash and cash equivalents

71,320

33,789

73,897

39,760

78,046

33,679

31,846

17,318

3,935

-10,567

-10,173

5,696

-9,191

7,843

288

-2,157

25,830

33,748

36,938

5,691

1,485

-3,154

7,363

23,013

11,465

11,875

5,623

7,738

3,461

5,665

-841

-162

159

899

1,187

210

1,043

0

0

0

Supplemental disclosure of cash flow information:
Cash paid for income taxes

9,685

8,269

8,109

4,918

5,290

8,296

7,587

7,118

4,641

1,515

1,429

1,464

1,405

859

832

994

848

849

1,492

1,317

1,215

1,308

753

698

1,324

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest on capital lease obligation

-

-

-

-

-

-

-

-

302

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental disclosure of non-cash investing and financing activities:
Property and equipment in accounts payable and accrued expenses

2,977

6,431

7,213

5,210

4,787

1,172

3,840

4,662

3,338

5,811

2,779

6,568

5,692

5,043

5,211

2,670

1,797

163

12

101

193

469

545

189

60

237

249

244

250

558

584

583

535

99

74

61

48

0

0

0

Right-of-use assets obtained in exchange for lease liabilities

15,650

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-